TY - JOUR
T1 - Vascular aspects in the pathophysiology of glaucomatous optic neuropathy
AU - Chung, Hak Sung
AU - Harris, Alon
AU - Evans, David W.
AU - Kagemann, Larry
AU - Garzozi, Hanna J.
AU - Martin, Bruce
N1 - Funding Information:
Supported in part by National Institutes of Health grant EY10801 (Dr. Harris), by an unrestricted grant from Research to Prevent Blindness Inc., New York, NY, the CS First Boston Research Fund of The Glaucoma Foundation, and the New York Glaucoma Research Institute. Dr. Harris is the 1995 William and Mary Greve International Research Scholar.
PY - 1999/6
Y1 - 1999/6
N2 - Glaucoma remains a major eye illness with unknown etiology. Although elevated intraocular pressure is clearly a major risk factor, vascular deficits may contribute to initiation and progression of glaucoma. When intraocular pressure is acutely elevated in healthy individuals, the resistance index (derived from the peak systolic and end-diastolic velocities and an indirect index of vascular resistance distal to the site of measurement) in the central retinal and posterior ciliary arteries increases progressively. This result implies that mechanical and vascular factors may be coupled in such a way that perfusion of the retina and optic nerve head may be influenced by changes in the intraocular pressure. Further, at night, when ophthalmic artery flow velocities fall as arterial blood pressure falls in glaucoma patients, the risk of disease progression may be increased. The constancy of these same flow velocities in age-matched healthy individuals points to a possible vascular autoregulatory defect in glaucoma. In addition, in normal-tension glaucoma, vasodilation (CO2 inhalation) normalizes retrobulbar arterial flow velocities, hinting that some vascular deficits in glaucoma may be reversible. Finally, Ca2+ channel blockade improves contrast sensitivity in patients with normal-tension glaucoma, who also show increased retrobulbar vessel flow velocities, a result suggesting that visual function loss may be linked to ocular ischemia. Emerging evidence points to a role of ischemia in the pathogenesis of glaucoma, suggesting that treatments designed to improve ocular blood flow may benefit glaucoma patients.
AB - Glaucoma remains a major eye illness with unknown etiology. Although elevated intraocular pressure is clearly a major risk factor, vascular deficits may contribute to initiation and progression of glaucoma. When intraocular pressure is acutely elevated in healthy individuals, the resistance index (derived from the peak systolic and end-diastolic velocities and an indirect index of vascular resistance distal to the site of measurement) in the central retinal and posterior ciliary arteries increases progressively. This result implies that mechanical and vascular factors may be coupled in such a way that perfusion of the retina and optic nerve head may be influenced by changes in the intraocular pressure. Further, at night, when ophthalmic artery flow velocities fall as arterial blood pressure falls in glaucoma patients, the risk of disease progression may be increased. The constancy of these same flow velocities in age-matched healthy individuals points to a possible vascular autoregulatory defect in glaucoma. In addition, in normal-tension glaucoma, vasodilation (CO2 inhalation) normalizes retrobulbar arterial flow velocities, hinting that some vascular deficits in glaucoma may be reversible. Finally, Ca2+ channel blockade improves contrast sensitivity in patients with normal-tension glaucoma, who also show increased retrobulbar vessel flow velocities, a result suggesting that visual function loss may be linked to ocular ischemia. Emerging evidence points to a role of ischemia in the pathogenesis of glaucoma, suggesting that treatments designed to improve ocular blood flow may benefit glaucoma patients.
KW - Autoregulation
KW - Ca channel blocker
KW - Intraocular pressure
KW - Ischemia
KW - Nocturnal ocular blood flow
KW - Vasospasm
UR - http://www.scopus.com/inward/record.url?scp=0038824378&partnerID=8YFLogxK
U2 - 10.1016/S0039-6257(99)00050-8
DO - 10.1016/S0039-6257(99)00050-8
M3 - Article
C2 - 10416746
AN - SCOPUS:0038824378
SN - 0039-6257
VL - 43
SP - S43-S50
JO - Survey of Ophthalmology
JF - Survey of Ophthalmology
IS - 6 SUPPL.
ER -